GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Adam (ADAM) [hlAlert]

Rating:
Buy ADAM
up 4.25 %

A.d.a.m. Inc. (ADAM) rated Buy with price target $5 by Roth Capital

Posted on: Thursday,  Mar 19, 2009  10:25 AM ET by Roth Capital

Roth Capital rated Buy Adam (NASDAQ: ADAM) on 03/19/2009. Previously Roth Capital rated Buy Adam (NASDAQ: ADAM) on 08/08/2007., when
the stock price was $7.29. Since then, Adam has gained 4.25% as of 02/07/2011's recent price of $7.60.
If you would have followed the previous Roth Capital's recommendation on ADAM, you would have gained 4.25% of your investment in 1279 days.

Adam Inc. is a leading developer of interactive health and medical information for consumers, students and healthcare professionals. A.D.A.M.'s products combine physician-reviewed text, medical illustrations, multimedia animation, interactive tools and technology thatexplain complex medical and health subject matter in a way that is easily understood by the reader.

ROTH researches emerging growth equities in the media, technology, telecommunications, healthcare, consumer, energy and industrial sectors. The research is focused on companies with market capitalization of between $100 million - $1 billion. Our coverage universe includes approximately 180 small cap growth companies around the globe including several companies from China. With an average market cap of approximately $500 million, our objective is to identify rapidly growing companies with significant long term growth prospects.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/19/2009 10:25 AM Buy
None
2.62 5.00
as of 12/31/2009
1 Week up  68.80 %
1 Month up  68.00 %
3 Months up  103.73 %
1 YTD up  77.25 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/7/2008 10:25 AM Buy
None
4.06 7.00
8/8/2007 9:25 AM Buy
None
7.29 9.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy